Immucell Key Ratios (2010-2026)

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Jun2026
Profitability
Gross Margin (Quarter)	45.67%	46.96%	47.04%	51.72%	44.22%	38.49%	25.37%	8.73%	29.55%	23.48%		31.63%	2,043.01%	26.34%	36.53%	41.58%	43.72%	42.92%	38.16%	33.92%
EBT Margin (Quarter)	3.11%	3.03%	1.38%	8.57%	-17.69%	-13.58%	-42.61%	-67.13%	-39.01%	-17.41%		-6.01%	-2,540.78%	-11.65%	6.72%	17.96%	7.82%	-2.46%	-37.32%	26.17%
EBIT Margin (Quarter)	4.74%	5.26%	2.67%	9.51%	-16.03%	-12.86%	-41.77%	-65.46%	-36.93%	-21.94%		-4.13%	-2,302.22%	-9.56%	8.02%	13.85%	8.84%	0.36%	-0.76%	26.93%
EBITDA Margin (Quarter)	4.74%	5.26%	2.67%	9.51%	-16.03%	-12.86%	-41.77%	-65.46%	-36.93%	-21.94%		-4.13%	-2,302.22%	-9.56%	8.02%	13.85%	8.84%	0.36%	-0.76%	26.93%
Operating Margin (Quarter)	4.74%	5.26%	2.67%	9.51%	-16.03%	-12.86%	-41.77%	-65.46%	-36.93%	-21.94%		-4.13%	-2,302.22%	-9.56%	8.02%	13.85%	8.84%	0.36%	-0.76%	26.93%
Net Margin (Quarter)	3.11%	2.87%	1.36%	8.56%	-11.96%	-13.66%	-41.23%	-67.17%	-39.06%	-17.42%		-6.03%	-2,543.00%	-11.67%	6.64%	17.94%	7.79%	-2.54%	-37.36%	25.53%
FCF Margin (Quarter)	-3.27%	-8.09%	-2.14%	-2.82%	-14.76%	-41.54%	-71.29%	-99.93%	-39.34%	-17.20%		4.80%	782.08%	-12.11%	3.38%	15.43%	22.44%	-32.26%	20.40%
Efficiency
Inventory Average (Quarter)	2.27M	2.54M	2.88M	3.26M	4.02M	4.96M	5.68M	6.18M	6.93M	7.46M	7.60M	7.48M	7.22M	7.38M	7.29M	7.23M	7.83M	9.05M	9.53M	9.17M
Assets Average (Quarter)	41.68M	43.98M	44.35M	45.58M	46.34M	46.19M	45.63M	43.99M	43.57M	44.28M	44.18M	43.43M	42.45M	43.15M	44.77M	45.36M	46.17M	46.23M	44.13M	44.58M
Invested Capital (Quarter)	0.77M	0.78M	0.81M	0.95M	0.97M	1.00M	1.04M	1.00M	1.00M	1.41M	1.43M	1.44M	1.46M	1.48M	1.50M	1.52M	1.54M	1.59M	1.61M	1.51M
Asset Utilization Ratio (Quarter)	0.39	0.40	0.43	0.46	0.44	0.44	0.41	0.36	0.36	0.37	0.28	0.37	0.30	0.31	0.47	0.48	0.61	0.60	0.63	0.60
Leverage & Solvency
Interest Coverage Ratio (Quarter)	0.19	0.25	1.96	0.45	-0.79	-4.84	-17.44	-25.07	1.15	1.29		-2.06	1.20	0.30	4.98	7.74	0.07	0.00	-0.38	20.23
Debt Ratio (Quarter)	0.21	0.21	0.21	0.23	0.23	0.23	0.23	0.23	0.22	0.28	0.27	0.27	0.27	0.25	0.23	0.26	0.21	0.21	0.21	0.21
Times Interest Earned (Quarter)	0.19	0.25	1.96	0.45	-0.79	-4.84	-17.44	-25.07	1.15	1.29		-2.06	1.20	0.30	4.98	7.74	0.07	0.00	-0.38	20.23
Valuation
Enterprise Value (Quarter)	-10.70M	-10.50M	-10.19M	-11.82M	-11.04M	-8.83M	-5.79M	-3.10M	-1.45M	-1.99M	-0.98M	-0.96M	-1.32M	-3.81M	-3.76M	-4.60M	-6.00M	-3.89M	-3.81M	-8.86M
Return Ratios
Return on Sales (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-0.01%	0.00%	0.00%	0.00%	0.00%	-0.25%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Capital Employed (Quarter)	-2.64%	-1.25%	0.62%	2.80%	0.84%	-1.20%	-5.40%	-12.76%	-14.76%	-15.58%	-11.87%	-7.11%	-7.58%	-5.85%	-4.06%	-0.54%	4.16%	5.51%	4.11%	6.14%
Return on Invested Capital (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Assets (Quarter)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Research Tools

Datasets

Plans

Developers

Immucell ICCC Ratios (2010-2026)

Research Tools

Datasets

Plans

Developers

Immucell ICCC Ratios (2010-2026)

Create an account

Sign In

Reset Password